PR Greipp

829 total citations
12 papers, 635 citations indexed

About

PR Greipp is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, PR Greipp has authored 12 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 5 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in PR Greipp's work include Multiple Myeloma Research and Treatments (12 papers), Cancer Treatment and Pharmacology (4 papers) and Hematopoietic Stem Cell Transplantation (2 papers). PR Greipp is often cited by papers focused on Multiple Myeloma Research and Treatments (12 papers), Cancer Treatment and Pharmacology (4 papers) and Hematopoietic Stem Cell Transplantation (2 papers). PR Greipp collaborates with scholars based in United States. PR Greipp's co-authors include Rafaël Fonseca, MA Gertz, RA Kyle, MQ Lacy, MR Litzow, TE Witzig, S. Vincent Rajkumar, Angela Dispenzieri, Susan M. Geyer and David Harrington and has published in prestigious journals such as Leukemia, Bone Marrow Transplantation and PubMed.

In The Last Decade

PR Greipp

12 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
PR Greipp United States 11 577 414 289 114 38 12 635
S. Mattox United States 6 672 1.2× 423 1.0× 300 1.0× 123 1.1× 56 1.5× 7 742
David Siegel United States 9 390 0.7× 341 0.8× 265 0.9× 43 0.4× 32 0.8× 23 529
Daniele Derudas Italy 9 494 0.9× 369 0.9× 258 0.9× 127 1.1× 51 1.3× 30 624
Roberto Mina Italy 15 564 1.0× 483 1.2× 380 1.3× 84 0.7× 37 1.0× 51 679
Norbert Grząśko Poland 13 356 0.6× 285 0.7× 237 0.8× 49 0.4× 40 1.1× 39 488
Vladimír Maisnar Czechia 13 393 0.7× 323 0.8× 238 0.8× 92 0.8× 16 0.4× 80 467
Mary McKenney United States 8 769 1.3× 655 1.6× 411 1.4× 124 1.1× 36 0.9× 11 871
Alessandra Bertola Italy 10 520 0.9× 369 0.9× 330 1.1× 63 0.6× 20 0.5× 13 569
Mamoun Dib France 9 644 1.1× 459 1.1× 341 1.2× 75 0.7× 41 1.1× 14 696
Zdeněk Adam Czechia 11 521 0.9× 418 1.0× 313 1.1× 81 0.7× 19 0.5× 30 586

Countries citing papers authored by PR Greipp

Since Specialization
Citations

This map shows the geographic impact of PR Greipp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by PR Greipp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PR Greipp more than expected).

Fields of papers citing papers by PR Greipp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by PR Greipp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by PR Greipp. The network helps show where PR Greipp may publish in the future.

Co-authorship network of co-authors of PR Greipp

This figure shows the co-authorship network connecting the top 25 collaborators of PR Greipp. A scholar is included among the top collaborators of PR Greipp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with PR Greipp. PR Greipp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Rajkumar, S. Vincent, Angela Dispenzieri, Rafaël Fonseca, et al.. (2001). Thalidomide for previously untreated indolent or smoldering multiple myeloma. Leukemia. 15(8). 1274–1276. 134 indexed citations
3.
Fonseca, Rafaël, David Harrington, K J Henderson, et al.. (2001). Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy. Leukemia. 15(6). 981–986. 100 indexed citations
4.
Gertz, MA, MQ Lacy, DJ Inwards, et al.. (2000). Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma. Bone Marrow Transplantation. 26(1). 45–50. 30 indexed citations
5.
Rajkumar, S. Vincent, Rafaël Fonseca, Angela Dispenzieri, et al.. (2000). Effect of complete response on outcome following autologous stem cell transplantation for myeloma. Bone Marrow Transplantation. 26(9). 979–983. 50 indexed citations
6.
Rajkumar, S. Vincent, Rafaël Fonseca, MQ Lacy, et al.. (1999). Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma. Bone Marrow Transplantation. 24(5). 497–503. 40 indexed citations
7.
Rajkumar, S. Vincent, Rafaël Fonseca, MQ Lacy, et al.. (1999). Beta2-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma. Bone Marrow Transplantation. 23(12). 1261–1266. 29 indexed citations
8.
Rajkumar, S. Vincent, Rafaël Fonseca, MQ Lacy, et al.. (1999). Autologous stem cell transplantation for relapsed and primary refractory myeloma. Bone Marrow Transplantation. 23(12). 1267–1272. 51 indexed citations
9.
Lacy, MQ, DJ Inwards, PR Greipp, et al.. (1999). Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma. Bone Marrow Transplantation. 23(3). 221–226. 26 indexed citations
10.
11.
Garton, John P., MA Gertz, Thomas E. Witzig, et al.. (1995). Epoetin alfa for the treatment of the anemia of multiple myeloma. A prospective, randomized, placebo-controlled, double-blind trial.. PubMed. 155(19). 2069–74. 63 indexed citations
12.
Greipp, PR, et al.. (1994). Bone marrow aspirate immunofluorescent and bone marrow biopsy immunoperoxidase staining of plasma cells in histologically occult plasma cell proliferative marrow disorders.. PubMed. 118(8). 811–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Mattox Breakdown of academic impact, for papers by David Siegel Breakdown of academic impact, for papers by Daniele Derudas Breakdown of academic impact, for papers by Roberto Mina Breakdown of academic impact, for papers by Norbert Grząśko Breakdown of academic impact, for papers by Vladimír Maisnar Breakdown of academic impact, for papers by Mary McKenney Breakdown of academic impact, for papers by Alessandra Bertola Breakdown of academic impact, for papers by Mamoun Dib Breakdown of academic impact, for papers by Zdeněk Adam
Rankless by CCL
2026